IBER   $10.18  -0.29% Market Closed

Ibere Pharmaceuticals
Total Cash 4.45K
totalCashPerShare 0.0
EBITDA
Total Debt 158.87K
quickRatio 0.009
currentRatio 0.241
Total Revenue
debtToEquity
Revenue/Share
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -682.92K
earningsGrowth -0.54
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 175.76M
forwardPE
floatShares 12.47M
sharesOutstanding 13.80M
sharesShort 20.60K
sharesShortPriorMonth 4.88K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.0
heldPercentInstitutions 0.98%
Short Ratio help_outline 0.14%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -0.338
Price To Book help_outline
earningsQuarterlyGrowth -0.54
netIncomeToCommon 6.19M
trailingEps 0.59%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 58
lastUpdated April 22, 2023, 2:23 p.m.